Reuters: Health
Australian biotech firm CSL Ltd said on Wednesday it will start local development of an immunoglobulin product to treat serious cases of COVID-19, the disease caused by the novel coronavirus.
Australia's CSL to start work on immunoglobulin product to treat COVID-19
Australia's CSL to start work on immunoglobulin product to treat COVID-19
Reuters: Health
Australian biotech firm CSL Ltd said on Wednesday it will start local development of an immunoglobulin product to treat serious cases of COVID-19, the disease caused by the novel coronavirus.
Reuters: Health
Australian biotech firm CSL Ltd said on Wednesday it will start local development of an immunoglobulin product to treat serious cases of COVID-19, the disease caused by the novel coronavirus.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment